covid and semaglutide Weight loss drug Wegovy reduced risk of COVID-19 deaths: Study Taking Semaglutide During COVID: Safety

The cardiovascular protection is also real

The thymus is very active in children and adolescents

For the weekly injection (2.4 mg), the STEP 1 trial showed sustained, clinically relevant weight reduction versus placebo in adults with overweight or obesity, as published in PubMed and in The New England Journal of Medicine

Separate-vials Reconstitution Reference Compound Cagrilintide Vial size 5 mg BAC water 2.0 mL Concentration 2.5 mg/mL Weekly draw at 2.4 mg 0.96 mL = 96 units U-100 Compound Cagrilintide Vial size 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL Weekly draw at 2.4 mg 0.72 mL = 72 units U-100 Compound Semaglutide Vial size 5 mg BAC water 2.0 mL Concentration 2.5 mg/mL Weekly draw at 2.4 mg 0.96 mL = 96 units U-100 Compound Semaglutide Vial size 10 mg BAC water 3.0 mL Concentration 3.33 mg/mL Weekly draw at 2.4 mg 0.72 mL = 72 units U-100 Volumes near 1 mL exceed standard U-100 / 0.3 mL syringe capacity

He made sure I understood all the possible risk while making me feel confident there would be no complications

#GLP1 #MetabolicHealth #ObesityIsADisease #BeyondWeightLoss #CardioMetabolic #FutureOfHealthcare #HealthcareLeadership #PharmaInnovation #PatientCentricity #DigitalHealth #RealWorldEvidence Well all i can say at the core, GLP-1 biology exposes a hard truth we ignored for decades